COMPARATIVE ONCOLOGY: CANINE AND HUMAN CANCER INSIGHTS
Clicks: 81
ID: 311882
2024
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
24.0
/100
81 views
8 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #5 of 14 articles by views in Gomal Journal of Life Sciences
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In this paper we present a comprehensive comparison of cancer treatment in dogs and humans with the emphasis put on the similar molecular etiologies, clinical presentation, and treatment strategies. Malignancies such as osteosarcoma, lymphoma, and melanoma are biologically similar and develop, grow, and are treated similarly within various species, according to the findings of the study as it integrated epidemiological data, molecular informing, and efficacy of treatments among the various species. The statistics indicate that dogs and human beings have numerous similarities regarding the genetic alterations characterized by an alteration of TP53, PTEN, and BRAF; the issues of signalling networks encompass PI3K/AKT and MAPK. According to Clinical trial data, canine oncology is an effective method to test new chemo therapies, targeted medications and immunotherapies in a short time. This has gone a long way in influencing how human beings deal with cancer. There has also been an easier way to diagnose and treat issues at an earlier stage due to aspects of improvement in diagnostic imaging, molecular testing, and the decreased invasiveness of biopsies in animals and people. The results of the comparative survival analyses reveal that although similarities in therapeutic responses often occur in congruence among species, pharmacokinetic differences, immune effects, and comorbidity make it necessary to adapt the responses to each species. In this study, the researchers demonstrate the potential positive impacts of integrating One Health approach to oncology. To illustrate, trans-species collaborative studies would result in faster new discoveries, the narrowing of gaps between research and practice, and the improved outcomes of the patient. Its findings point to enhanced collaboration between veterinarians and physicians to expand comparative oncology data sets, facilitate the more convenient incorporation of clinical research and enhance individualised cancer treatment to both dogs and humans.
| Reference Key |
imported_1773407789_69b40e2dc7d4b
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rida Naz |
| Journal | Gomal Journal of Life Sciences |
| Year | 2024 |
| DOI |
DOI not found
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.